JIVE ETF Near $90: International Value Rally That Still Looks Investable

JIVE ETF (NASDAQ:JIVE) – international value winner now priced near the top of its range

JIVE ETF price action, range and liquidity

JIVE ETF (NASDAQ:JIVE) trades around $90.12, up roughly 0.08% on the day from a previous close of $90.04, after moving between $89.13 and $90.21 in the latest session and inside a 52-week range of $54.62 to $91.37. That puts the fund essentially at the ceiling of its one-year range, with only about 1.4% between the current price and the 52-week high. Average daily volume near 341K–420K shares is more than enough for institutional-size tickets, and a quoted median bid/ask spread around 0.06% confirms that secondary-market liquidity is tight and transaction costs are modest for an active product of this size. Over the last year, the price has exploded from the mid-50s to just under $90–$91, a move of roughly 45–55% depending on the exact measurement window, outpacing both U.S. broad indices and standard international benchmarks.

JIVE ETF structure: broad ex-US value with a deliberate financials bet

The portfolio holds roughly 370–380 stocks (about 371 in the latest breakdown), with the top ten names accounting for less than 15% of assets and no single position above 3%. That level of dispersion means stock-specific blow-ups are diluted, but factor and regional bets are very explicit. Geographically, about 50% of assets sit in EMEA (Europe, Middle East and Africa), around 25% in Asia ex-Japan, roughly 15% in Japan, and U.S. exposure is below 5%. Investors are effectively buying a global ex-U.S. value sleeve tilted toward Europe and developed Asia, not a “world” fund with another hidden U.S. overweight. Sector allocation is where the conviction really shows. Financials sit above 35% of the fund, making JIVE ETF an aggressive expression on global banks, insurers and diversified financials. Everything else is sized down by comparison: energy, industrials and other cyclicals are meaningful but secondary; technology, utilities and real estate are smaller slices. This is value through the classic lenses of banks, energy, cyclicals and non-U.S. blue-chips, not a growth-at-a-reasonable-price product hiding under a value label.

Assets, fees, yield and turnover: what you pay and what you get back

Net assets have climbed to roughly $1.5–1.8 billion, reflecting both performance and fresh inflows as investors rotate into non-U.S. value. The expense ratio is 0.55%, firmly in active-management territory and noticeably higher than low-cost cap-weighted international ETFs, but in line with other quantitative active value products. Turnover around 55% confirms this is a genuinely active book, not a semi-static smart-beta wrapper; the manager is willing to recycle roughly half the portfolio each year as signals change. On the income side, the fund offers a 30-day SEC yield near 3.0% (about 3.01%) and a 12-month trailing dividend yield around 2.3–2.6% (roughly 2.35–2.56%, depending on the measure and date). That yield profile is not a high-income product like a covered-call ETF, but it is meaningfully above the S&P 500’s dividend yield and provides a tangible cash component to total return, especially attractive when multiples across global equities are rich.

Performance context: JIVE ETF versus other international value and ex-US strategies

The initial leg of outperformance has been aggressive. One set of institutional signals shows 1-year alpha of about +12.3% for JIVE ETF versus a traditional ex-U.S. value benchmark, with most of that gap built in the 2025–early 2026 period. Over the same broad window, international stocks ex-U.S. delivered roughly 30–34% returns, while U.S. broad indices came in closer to the mid-teens. JIVE’s roughly 46–53% price gain over twelve months therefore beats both its style bucket and the mainstream ex-U.S. indices. Against a deep-value peer like GMO International Value ETF, which has posted roughly 55% total returns since late 2024, and a shareholder-yield-focused fund like FYLD that has also outperformed its benchmark, JIVE ETF is in the same performance band but with a more concentrated bet on financials and classic value sectors. Where many cap-weighted ex-U.S. funds still look like diluted blends of quality and growth, JIVE is a purer value factor expression that has caught the right macro regime: weaker U.S. dollar, European and Japanese equity revival, and a re-rating of banks and cyclicals from distressed to “normal” valuations.

Valuations: value factor no longer cheap, but still offers earnings and dividends

The key question is what is left after that run. Reworking the data, the implied forward P/E for JIVE ETF’s portfolio clusters in the 14–16x range. Historically, that is not a distress multiple for ex-U.S. value; it is the upper half of the distribution. By region, the core exposures highlighted for JIVE—Europe, U.K., Japan and other developed ex-U.S. markets—are sitting close to the 90th percentile of their forward P/E ranges since 2023. By sector, both the value basket as a whole and global financials in particular are trading above the 90th percentile of their 20-year forward P/E distributions. In other words, the market has already repriced “cheap” regions and sectors aggressively. That limits further upside from multiple expansion alone. The offset is that a value portfolio like this typically offers more stable earnings growth paths and explicit cash distributions. JIVE’s ~2.5–3.0% yield plus underlying earnings growth means that even if valuation multiples stall or compress modestly, total returns can still be reasonable, provided earnings do not roll over.

Trading levels and price map: where JIVE ETF becomes attractive or dangerous

On the trading side, quantitative signal providers have mapped out a detailed level structure around JIVE ETF. Earlier in the current rally, a long-term cluster of supports sat near $80.21, $82.75, $85.04 and $87.44, with the then-current price anchored around that upper node. Institutional strategy templates translate those levels into actionable bands. A “position trade” long entry is flagged around $85.04, with an upside target near $91.84 and a tight stop around $84.79, effectively using the low-to-mid-80s zone as the line where longer-term support should hold. Momentum breakout parameters point to a trigger at roughly $87.91, target around $89.22, and stop near $87.66, capturing short-term continuation when JIVE pushes through minor resistance. A hedging-oriented short template looks for entries around $87.74, aiming back toward $83.35 with stops near $88.00, which makes sense for investors who are structurally long value but want to tactically lean against overstretched levels. With the price now at $90.12 and the 52-week high at $91.37, JIVE is trading slightly above the most recent resistance cluster and very close to that $91–92 upside band. That positioning says two things: first, the fund is no longer in the “cheap entry” zone; second, any further push higher will likely require either stronger earnings revisions from its underlying holdings or a late-cycle melt-up in value, both of which are possible but not guaranteed.

Macro and factor backdrop: why JIVE ETF outperformed and what can change it

JIVE has benefited from a macro mix that strongly favors its design. A weakening U.S. dollar in 2025 boosted returns for dollar-based investors holding foreign assets, effectively magnifying local-currency gains. European indices such as Spain’s IBEX and Germany’s DAX posted returns in the 20–50% range, while Japan’s equity market gained around a quarter as corporate governance reforms and shareholder-friendly policies gained traction. Emerging markets also contributed, with countries like South Korea riding the AI hardware cycle and Latin America enjoying better terms of trade. In that environment, international value ETFs naturally outperformed U.S. large-cap growth, and JIVE’s heavy financials and cyclicals exposure amplified the move. The risk is that this backdrop shifts. If the dollar stabilizes or reverses higher, some of the FX tailwind disappears. If central banks cut rates too aggressively and the yield curve bull-flattens, the net-interest margin support for banks fades. If global growth slows, loan growth and credit quality deteriorate. All of those are standard cyclicality risks for a fund with roughly a third of its exposure in financials and more in other rate-sensitive, capital-intensive sectors.

Risk profile: financials concentration, policy sensitivity and valuation risk

The main structural risk in JIVE ETF is its hyper-concentration in financials as the core engine of factor exposure. That sector is tightly linked to monetary policy, curve shape and systemic confidence. At the moment, a bear-steepening configuration, where long yields stay elevated while front-end policy rates begin to edge down, is supportive for bank margins. But curves are cyclical, and the economic system ultimately needs lower long-term rates to sustain growth. When curves bull-flatten or invert, the same banks and insurers that drove JIVE’s outperformance can suddenly de-rate. Beyond rates, investors face standard non-U.S. risks: political shocks in key European markets, regulatory swings, currency volatility and occasional liquidity squeezes in smaller underlying holdings. Overlaid on that, valuations at or above the 90th percentile for both the value factor and global financials leave less margin for error. A negative shock to earnings or a shift in investor preference back toward U.S. growth can translate faster into price damage when you start from an already-re-rated base.

Verdict on JIVE ETF (NASDAQ:JIVE): Hold at $90, Buy on pullbacks, not a Sell yet

Pulling everything together, JIVE ETF (NASDAQ:JIVE) at about $90 is no longer the deep-value secret it was when it traded in the mid-50s. The price is at the top of its $54.62–$91.37 one-year range, the portfolio’s 14–16x forward P/E sits near the top end of historical ex-U.S. value multiples, and sector and regional exposures are already heavily re-rated. On the positive side, you still have a 2.5–3.0% yield, reasonably stable earnings from diversified non-U.S. large and mid-caps, strong relative strength versus both U.S. and international benchmarks, and evidence that the manager can generate double-digit alpha in the right regimes. At current levels, the risk-reward is no longer asymmetric enough to justify calling it a fresh high-conviction buy. The more rational call is straightforward. At around $90, JIVE is a Hold for existing investors who rode the move; it remains a viable core international value sleeve, but new capital is better deployed on pullbacks into the $82–85 support zone, where long-term signals and valuation both re-align. Only if the fund were to push materially above the low-90s without a corresponding step-up in earnings and dividend power would it drift toward a Sell on valuation grounds. For now, JIVE ETF is a Hold with a buy-the-dip bias, not something to chase aggressively at the top of its range.

That's TradingNEWS